本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ikena Oncology, Inc.

1.43
0.0000
成交量:- -
成交额:- -
市值:6,900.97万
市盈率:- -
高:1.43
开:1.43
低:1.43
收:1.43
52周最高:23.28
52周最低:1.43
股本:4,825.85万
流通股本:3,328.22万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(LYR):-1.0202
净资产收益率:-23.76%
总资产收益率:-18.32%
市净率:0.60
市盈率(LYR):-1.40

数据加载中...

2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/06

SEC问询函

Form CORRESP - Correspondence
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]